Literature DB >> 3294012

Kawasaki disease: monitoring of circulating immune complexes.

E Salo1, R Kekomäki, P Pelkonen, O Ruuskanen, M Viander, O Wagner.   

Abstract

We followed the levels of circulating immune complexes (CIC) in 27 patients with Kawasaki disease (KD) from the acute stage of the disease through convalescence, using the test for platelet-reactive IgG-IC, and C1q-binding and conglutinin-binding enzyme immunoassays. CIC were detected by one or more techniques in all but one patient. Positive results were obtained most often with the test for platelet-reactive IgG-IC. Measurement of complement components C3 and C4 in 14 patients revealed an increase in C3 levels during the first few weeks of the disease and normal levels of C4. The blood platelet count correlated directly with the level of platelet-reactive IgG-IC. The highest levels of CIC were found during weeks 3 through 7 after the onset of disease. Measurement of CIC is, however, not applicable to the clinical follow-up of patients with KD.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3294012     DOI: 10.1007/bf00496414

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  15 in total

1.  Intravenous immunoglobulin in Kawasaki syndrome: a progress report.

Authors:  M E Melish
Journal:  Pediatr Infect Dis       Date:  1986 May-Jun

2.  Circulating immune complexes in Kawasaki syndrome.

Authors:  W H Mason; S C Jordan; R Sakai; M Takahashi; B Bernstein
Journal:  Pediatr Infect Dis       Date:  1985 Jan-Feb

Review 3.  Immune-complex-mediated biologic effects.

Authors:  R C Wiggins; C G Cochrane
Journal:  N Engl J Med       Date:  1981-02-26       Impact factor: 91.245

Review 4.  Kawasaki syndrome (the mucocutaneous lymph node syndrome).

Authors:  M E Melish
Journal:  Annu Rev Med       Date:  1982       Impact factor: 13.739

5.  Interference by rheumatoid factor and C1q in the detection of IgG complexes: studies of model systems by ELISA.

Authors:  O Wager; P Lindstrøm
Journal:  Scand J Immunol       Date:  1982-03       Impact factor: 3.487

6.  Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series.

Authors:  O Wager; P Lindström; J A Räsänen; R Kekomäki; B Ziola; A Salmi; H Isomäki; B Skrifvars; K Penttinen
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

7.  Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis.

Authors:  M Levin; P C Holland; T J Nokes; V Novelli; M Mola; R J Levinsky; M J Dillon; T M Barratt; W C Marshall
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-18

8.  Impaired granulocyte chemotaxis and increased circulating immune complexes in Kawasaki disease.

Authors:  S Ono; T Onimaru; K Kawakami; M Hokonohara; K Miyata
Journal:  J Pediatr       Date:  1985-04       Impact factor: 4.406

9.  Outbreak of Kawasaki syndrome in Finland.

Authors:  E Salo; P Pelkonen; O Pettay
Journal:  Acta Paediatr Scand       Date:  1986-01

10.  Mucocutaneous lymph-node syndrome (Kawasaki disease): probable soluble-complex disorder.

Authors:  C Fossard; R A Thompson
Journal:  Br Med J       Date:  1977-04-02
View more
  6 in total

1.  Antibodies to native type III collagen in the serum of patients with Kawasaki disease.

Authors:  S Kobayashi; N Wada; M Kubo
Journal:  Eur J Pediatr       Date:  1992-03       Impact factor: 3.183

2.  Early decreased plasma levels of factor B and C5a are important biomarkers in children with Kawasaki disease.

Authors:  Qing-Mei Zou; Xiao-Hui Li; Rui-Xia Song; Nan-Ping Xu; Ting Zhang; Ming-Ming Zhang; Yao Lin; Lin Shi; Jin Fu; Xiao-Dai Cui
Journal:  Pediatr Res       Date:  2015-05-04       Impact factor: 3.756

3.  Study of the autoantibody profile after the acute phase of Kawasaki disease in a cohort of children from North India.

Authors:  R Venkatraman; S Singh; R W Minz
Journal:  Rheumatol Int       Date:  2005-11-25       Impact factor: 2.631

Review 4.  Kawasaki syndrome.

Authors:  A H Rowley; S T Shulman
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

5.  Distinct variations of antibody secreting cells and memory B cells during the course of Kawasaki disease.

Authors:  Meng Xu; Yanfang Jiang; Jinghua Wang; Jinxiang Liu; Congcong Liu; Deying Liu; Sirui Yang
Journal:  BMC Immunol       Date:  2019-06-03       Impact factor: 3.615

Review 6.  Kawasaki Disease: The Role of Immune Complexes Revisited.

Authors:  Stephanie Menikou; Paul R Langford; Michael Levin
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.